iLIVE was a 4-year research project funded by the European Union's Horizon 2020 programme that developed novel, evidence–based and sustainable interventions to relieve the symptoms and suffering that occur at end of life for patients with advanced chronic illnesses and their families. It was delivered through nine interconnected Work Packages coordinated across an international consortium of 14 organisations from 13 countries.